Health Service Interventions for Cancer Control in Developing Countries

[1]  L Påhlman,et al.  Improved survival with preoperative radiotherapy in resectable rectal cancer. , 1997, The New England journal of medicine.

[2]  J. Kievit,et al.  Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. , 2003, Journal of the National Cancer Institute.

[3]  David K Whynes,et al.  Cost-Effectiveness of Screening for Colorectal Cancer: Evidence from the Nottingham Faecal Occult Blood Trial , 2004, Journal of medical screening.

[4]  H. Collette,et al.  Evaluation of a breast cancer screening programme--the DOM project. , 1992, European journal of cancer.

[5]  J. V. van Meerbeeck,et al.  Screening and diagnosis of NSCLC. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  R. Hayward,et al.  Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. , 2001, The American journal of medicine.

[7]  M. Weinstein,et al.  A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine , 2003, International journal of cancer.

[8]  A. Stiggelbout,et al.  Cost-effectiveness analysis of colorectal cancer treatments. , 2002, European journal of cancer.

[9]  Daron G Ferris,et al.  Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial , 2004, The Lancet.

[10]  P. Roderick,et al.  Cost-Effectiveness of Population Screening for Helicobacter Pylori in Preventing Gastric Cancer and Peptic Ulcer Disease, Using Simulation , 2003 .

[11]  B. Hillner,et al.  Tamoxifen should be cost-effective in reducing breast cancer risk in high-risk women. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  B. Yvonnet,et al.  Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. , 1994, Journal of hepatology.

[13]  E. Myers,et al.  Costs and Effectiveness of Alternative Strategies for Cervical Cancer Screening in Military Beneficiaries , 2002, Obstetrics and gynecology.

[14]  T. Wright,et al.  Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. , 2002, JAMA.

[15]  Alan D. Lopez,et al.  The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001 -- Global Burden of Disease and Risk Factors , 2006 .

[16]  HPV DNA Testing of Self-collected Vaginal Samples Compared With Cytologic Screening to Detect Cervical Cancer , 2000 .

[17]  J. Groopman,et al.  Translational strategies for cancer prevention in liver , 2003, Nature Reviews Cancer.

[18]  Christopher J L Murray,et al.  WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty , 2003, BMJ : British Medical Journal.

[19]  H. D. de Koning,et al.  Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. , 1995, Journal of the National Cancer Institute.

[20]  M. Tockman,et al.  Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. , 2002, Chest.

[21]  F. Sarasin,et al.  Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. , 1996, The American journal of medicine.

[22]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[23]  S. Gallivan,et al.  Evaluating cervical cancer screening programmes for developing countries , 1997, International journal of cancer.

[24]  H. Koning.  Breast cancer screening; cost-effective in practice? , 2000 .

[25]  J. Norum,et al.  Breast cancer screening by mammography in Norway. Is it cost-effective? , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  D. Parkin.  Cancer in Africa: epidemiology and prevention. , 2003, IARC scientific publications.

[27]  J. Mitchell,et al.  A DECISION MODEL AND COST-EFFECTIVENESS ANALYSIS OF COLORECTAL CANCER SCREENING AND SURVEILLANCE GUIDELINES FOR AVERAGE-RISK ADULTS , 2000, International Journal of Technology Assessment in Health Care.

[28]  W. Lawrence,et al.  Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. , 2002, Journal of the National Cancer Institute.

[29]  D. Coyle,et al.  Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer. , 2000, Journal of the National Cancer Institute.

[30]  J. Norum.  Adjuvant Cyclophosphamide, Methotrexate, Fluorouracil (CMF) in Breast Cancer: Is it Cost-effective? , 2000, Acta oncologica.

[31]  D. Owens,et al.  Helicobacter pylori and Gastric Cancer: What Are the Benefits of Screening Only for the CagA Phenotype of H. pylori? , 1999, Helicobacter.

[32]  K. Sikora,et al.  Essential drugs for cancer therapy: a World Health Organization consultation. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  Costa e Silva,et al.  Tools for advancing tobacco control in the XXIst century: policy recommendations for smoking cessation and treatment of tobacco dependence: tools for public health. , 2003 .

[34]  G. Omenn,et al.  Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.

[35]  John Eng,et al.  Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. , 2003, JAMA.

[36]  L. Coia,et al.  The structure of radiation oncology in the United States in 1994. , 1997, International journal of radiation oncology, biology, physics.

[37]  I. Johnstone,et al.  Helicobacter pylori Eradication and Gastric Preneoplastic Conditions , 2004, Cancer Epidemiology Biomarkers & Prevention.

[38]  B. Hillner,et al.  The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  P C Prorok,et al.  Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. , 2000, Journal of the National Cancer Institute.

[40]  M. Brown,et al.  Adjuvant therapy for stage III colon cancer: economics returns to research and cost-effectiveness of treatment. , 1994, Journal of the National Cancer Institute.

[41]  T. Wright.  Chapter 10: Cervical cancer screening using visualization techniques. , 2003, Journal of the National Cancer Institute. Monographs.

[42]  H. D. de Koning,et al.  Nationwide breast cancer screening programme fully implemented in The Netherlands. , 2001, Breast.

[43]  Martin L. Brown,et al.  Cost-effectiveness of breast cancer screening: Preliminary results of a systematic review of the literature , 2004, Breast Cancer Research and Treatment.

[44]  M H Gail,et al.  Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. , 1999, Journal of the National Cancer Institute.

[45]  Roberta M Ray,et al.  Randomized trial of breast self-examination in Shanghai: final results. , 2002, Journal of the National Cancer Institute.

[46]  S. Moss,et al.  Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico. , 1999, Archives of medical research.

[47]  Y. Ko,et al.  Trends in the incidence of hepatocellular carcinoma in boys and girls in Taiwan after large-scale hepatitis B vaccination. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[48]  M. Fiore,et al.  Effective tobacco dependence treatment. , 2002, JAMA.

[49]  S Wacholder,et al.  HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. , 2000, JAMA.

[50]  Shalini L Kulasingam,et al.  Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. , 2003, JAMA.

[51]  D M Parkin,et al.  Visual inspection with acetic acid in the early detection of cervical cancer and precursors , 1999, International journal of cancer.

[52]  J. Sachs.  Macroeconomics and health: investing in health for economic development , 2002 .

[53]  N. Lee,et al.  Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. , 2000, Journal of the National Cancer Institute.

[54]  Stephen Taplin,et al.  Early Detection of Breast Cancer in Countries with Limited Resources , 2003, The breast journal.

[55]  T. Powles,et al.  Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial , 1998, The Lancet.

[56]  James P. Hughes,et al.  The Theoretical Population-Level Impact of a Prophylactic Human Papilloma Virus Vaccine , 2002, Epidemiology.

[57]  Milton C Weinstein,et al.  Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. , 2004, Journal of the National Cancer Institute.

[58]  D. Parkin,et al.  Screening for liver cancer: results of a randomised controlled trial in Qidong, China , 2003, Journal of medical screening.

[59]  A. Sonnenberg,et al.  Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer , 2000, Annals of Internal Medicine.

[60]  C. Wheeler,et al.  A controlled trial of a human papillomavirus type 16 vaccine. , 2002, The New England journal of medicine.

[61]  A. Ezzat,et al.  Book review: National cancer control programmes, policies and managerial guidelines. , 1996, Annals of Saudi medicine.

[62]  P. Boyle,et al.  Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women , 1998, The Lancet.

[63]  A. Hillman,et al.  Declining Cost-Effectiveness of Screening for Disease: The Case of Gastric Cancer in Japan , 1995, International Journal of Technology Assessment in Health Care.

[64]  D. Alberts,et al.  Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. , 2000, The New England journal of medicine.

[65]  R. Rajkumar,et al.  Effective screening programmes for cervical cancer in low- and middle-income developing countries. , 2001, Bulletin of the World Health Organization.

[66]  S. Woolf,et al.  Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[67]  Guilbert Jj.  The world health report 2002 - reducing risks, promoting healthy life. , 2003 .

[68]  Catherine Legrand.  1687Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials : Early Breast Cancer Trialists' Collaborative Group (EBCTCG) , 2005 .

[69]  E. Keeler,et al.  Using Cost-Effectiveness Analysis to Define a Breast Cancer Benefits Package for the Uninsured , 2002, Breast Cancer Research and Treatment.

[70]  F. Bray,et al.  Cancer burden in the year 2000. The global picture. , 2001, European journal of cancer.

[71]  A. Sabichi,et al.  Cancer chemoprevention: progress and promise. , 1998, Journal of the National Cancer Institute.

[72]  A. Hall,et al.  The role of aflatoxins and hepatitis viruses in the etiopathogenesis of hepatocellular carcinoma: A basis for primary prevention in Guinea–Conakry, West Africa , 2002, Journal of gastroenterology and hepatology.

[73]  C. Earle,et al.  Economic decision analysis model of screening for lung cancer. , 2001, European journal of cancer.

[74]  T. Wright,et al.  Evaluation of alternative methods of cervical cancer screening for resource‐poor settings , 2000, Cancer.

[75]  G J van Oortmarssen,et al.  In search of the best upper age limit for breast cancer screening. , 1995, European journal of cancer.

[76]  V. Semiglazov,et al.  [Interim results of a prospective randomized study of self-examination for early detection of breast cancer (Russia/St.Petersburg/WHO)]. , 1999, Voprosy onkologii.

[77]  J D Habbema,et al.  A model for breast cancer screening , 1990, Cancer.

[78]  T. Wright,et al.  Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. , 2001, JAMA.

[79]  Teresa To,et al.  Mammography benefit in the Canadian National Breast Screening Study‐2: A model evaluation , 2004, International Journal of Cancer.

[80]  Alan D. Lopez,et al.  Global burden of disease and risk factors , 2006 .

[81]  Graham A. Colditz,et al.  Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.

[82]  S. Raab,et al.  De novo establishment and cost‐effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam , 2001, Cancer.

[83]  A. Mills,et al.  Unit costs of health care inputs in low and middle income regions , 2003 .

[84]  Mike Clarke,et al.  Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[85]  Deborah Schrag,et al.  The price tag on progress--chemotherapy for colorectal cancer. , 2004, The New England journal of medicine.

[86]  H. D. de Koning,et al.  Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality , 2004, British Journal of Cancer.

[87]  F. Alexander,et al.  A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies , 2001, Journal of medical screening.

[88]  J. Ferlay,et al.  Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .

[89]  Michael Pignone,et al.  Cost-Effectiveness Analyses of Colorectal Cancer Screening , 2002, Annals of Internal Medicine.

[90]  L. Påhlman,et al.  Cost-effectiveness of preoperative radiotherapy in rectal cancer: results from the Swedish Rectal Cancer Trial. , 2002, International journal of radiation oncology, biology, physics.

[91]  P. Rose,et al.  Analysis of the cost effectiveness of concurrent cisplatin-based chemoradiation in cervical cancer: implications from five randomized trials. , 2000, Gynecologic oncology.

[92]  T. Imperiale.  Aspirin and the prevention of colorectal cancer. , 2003, The New England journal of medicine.

[93]  H. Gurney,et al.  A cost‐utility approach to the use of 5‐fluorouracil and levamisole as adjuvant chemotherapy for Dukes’ C colonic carcinoma , 1993 .

[94]  J. Weissfeld,et al.  Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. , 2000, The New England journal of medicine.

[95]  E. Frodis,et al.  Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme , 2000, Journal of medical screening.

[96]  D. Jamison,et al.  Disease Control Priorities in Developing Countries , 1993 .

[97]  H. Whittle,et al.  Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. , 1999, Vaccine.

[98]  Mireille J. M. Broeders,et al.  Breast cancer screening programmes in 22 countries: current policies, administration and guidelines , 1998 .

[99]  Gillian D. Sanders,et al.  Cost Effectiveness of a Potential Vaccine for Human papillomavirus , 2003, Emerging infectious diseases.

[100]  B. Thomadsen,et al.  Postmastectomy radiotherapy in premenopausal Vietnamese and Chinese women with breast cancer treated in an adjuvant hormonal therapy study. , 2003, International journal of radiation oncology, biology, physics.

[101]  K. Simpson,et al.  Informing the Mammography Coverage Debate: Results of Meta-analysis, Computer Modeling, and Issue Analysis , 1991, International Journal of Technology Assessment in Health Care.

[102]  L. Marks,et al.  Assessing the cost-effectiveness of postmastectomy radiation therapy. , 1999, International journal of radiation oncology, biology, physics.

[103]  H. Glick,et al.  Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[104]  P. Singer,et al.  Quality end-of-life care: A global perspective , 2002, BMC palliative care.

[105]  T. Wright,et al.  Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More , 2004, Obstetrics and gynecology.